Invivo Corp.
This article was originally published in The Gray Sheet
Executive Summary
Secondary offering of 1 mil. shares of common stock grosses approximately $13.3 mil. The vital signs monitoring instrument firm's offering includes 900,000 shares from the company and 100,000 shares from a selling shareholder. Cruttenden Roth and Gerard Klauer Mattison & Co. were underwriters for the offering